This article has been updated to include additional information from the journal article.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Sequenom jumped as much as 15 percent in Thursday trade after the firm published results on its non-invasive fetal trisomy test in the online section of the American Journal of Obstetrics and Gynecology website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.